James M Stockman Cancer Institute is a clinical research site located in Frederick, Maryland, United States 21701.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
James M Stockman Cancer Institute has participated in 6 clinical trials with 5 currently active.
Therapeutic areas: Metastatic Breast Cancer, Breast Cancer, Metastatic Castration-resistant Prostate Cancer.
Sponsors: Elevation Oncology, Exact Sciences Corporation, Celgene.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
James M Stockman Cancer Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
James M Stockman Cancer Institute has 6 clinical trials on record, with 5 currently active. Their work covers Metastatic Breast Cancer, Breast Cancer, Metastatic Castration-resistant Prostate Cancer.
Yes — James M Stockman Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.